Publications by authors named "Michael Muto"

Claim this Profile
C
Cervical Cancer Reporting Lexicon: A Collaboration by the SAR Uterine and Ovarian Cancer DFP, ESUR Female Pelvic Imaging Working Group, and Asian Society of Abdominal Radiology.
Lauren A Roller, Aradhana M Venkatesan, Stephanie Nougaret, Elizabeth Sadowski, Nadeem R Abu-Rustum, Michael Muto

AJR Am J Roentgenol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Hysterectomy Versus Laparoscopic and Open Approaches: A Propensity Score-Matched Comparison of Outcomes.
Parmida Maghsoudlou, Nisse V Clark, Anna M C van Campen, Jon I Einarsson, Michael G Muto

J Minim Invasive Gynecol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcoma.
Kevin Tyan, Kevin X Liu, Alicia C Smart, Colleen M Feltmate, Neil S Horowitz, Michael G Muto

Gynecol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer Risk Among Germline / Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.
Kimia Sorouri, Filipa Lynce, Colleen M Feltmate, Michelle R Davis, Michael G Muto

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable remission in a patient with -amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-Paclitaxel.
Alexander J Neil, Michael G Muto, David L Kolin, Panagiotis A Konstantinopoulos

Gynecol Oncol Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing in the Diagnosis of Metastatic Lesions: Reclassification of a Glioblastoma as an Endometrial Cancer Metastasis to the Brain.
Shuk On Annie Leung, Olivia Foley, David Chapel, Annacarolina Da Silva, Marisa Nucci, Michael G Muto

Oncologist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system.
Jyothi P Jagannathan, Aida Steiner, Camden Bay, Eric Eisenhauer, Michael G Muto

Abdom Radiol (NY)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery.
Beryl Manning-Geist, Ann M Cathcart, Mackenzie W Sullivan, Andrea Pelletier, Stephanie Cham, Michael G Muto

Int J Gynecol Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions.
Mackenzie W Sullivan, Lauren Philp, Alexa N Kanbergs, Nida Safdar, Esther Oliva, Michael Muto

Gynecol Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samples.
Shuk On Annie Leung, Sarah Feldman, Rajeshwari Kalyanaraman, Vignesh Shanmugam, Michael J Worley, Michael G Muto

Am J Reprod Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 Interactions.
Katherine N Lynch, Joyce F Liu, Nikolas Kesten, Kin-Hoe Chow, Aniket Shetty, Michael G Muto

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mid-trimester cesarean scar pregnancy: a case report.
Mary Louise Fowler, Sarah Little, Michael Muto, Shruthi Mahalingaiah

Fertil Res Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.
Changxin Wan, Matthew P Keany, Han Dong, Linah F Al-Alem, Unnati M Pandya, Michael G Muto

Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancer.
Alexa N Kanbergs, Beryl L Manning-Geist, Andrea Pelletier, Mackenzie W Sullivan, Marcela G Del Carmen, Michael G Muto

Gynecol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female adnexal tumor of probable Wolffian Origin - A report of two cases at one institution.
Megan E Bunnell, Bridget M Donovan, Paige H Parrack, Michael G Muto, Neil S Horowitz

Gynecol Oncol Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
Beryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, Rachel M Clark, Marcela G Del Carmen, Michael G Muto

Am J Obstet Gynecol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC).
Helena M Ditzel, Kyle C Strickland, Emily E Meserve, Elizabeth Stover, Panagiotis A Konstantinopoulos, Michael G Muto

Int J Gynecol Pathol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
Beryl L Manning-Geist, Stephanie Alimena, Marcela G Del Carmen, Annekathryn Goodman, Rachel M Clark, Michael G Muto

Gynecol Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
Thing Rinda Soong, Brooke E Howitt, Alexander Miron, Neil S Horowitz, Frank Campbell, Michael G Muto

J Pathol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids.
Sarah J Hill, Brennan Decker, Emma A Roberts, Neil S Horowitz, Michael G Muto

Cancer Discov· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of a heterotopic pregnancy and ruptured rudimentary uterine horn.
Paula C Brady, Rose L Molina, Michael G Muto, Brenna Stapp, Serene S Srouji

Fertil Res Pract· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?
Beryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, Rachel M Clark, Marcela G Del Carmen, Michael G Muto

Gynecol Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial cancer with an rearrangement.
Jeffrey W Craig, Bradley J Quade, Michael G Muto, Laura E MacConaill

Cold Spring Harb Mol Case Stud· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.
Michelle Davis, Kyle Strickland, Sarah Rae Easter, Michael Worley, Colleen Feltmate, Michael Muto

Gynecol Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers.
Cindy M Yamamoto, Melanie L Oakes, Taku Murakami, Michael G Muto, Ross S Berkowitz

J Ovarian Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis